Current Clinical Research Trials for Myasthenia Gravis

Researchers at The GW Medical Faculty Associate’s Department of Neurology & Rehabilitation Medicine are conducting clinical research trials to learn more about treating myasthenia Gravis (MG). 

Clinical research trials search for new ways to prevent, understand and/or treat disease. The goal of these trials is to see if a new treatment, procedure or device works and is safe to use.  Participating in a research trial, as either a healthy volunteer or a patient volunteer, is an opportunity to help researchers find better treatments for others in the future.

The following are clinical research trials specific to myasthenia gravis:

Exploratory Study of Biomarkers Predicting Response to Immunosuppressive in Myasthenia Gravis 

Principal Investigator: Henry Kaminski, M.D.

Status of Research Trial: Active, currently recruiting

Sponsor of Research Trial: The George Washington University

Description of Research Trial: This is an exploratory pilot study that will aim to describe the immunologic profiles of MG patients receiving MG treatment.

Research Trial Contact Information:  For more information, interested participants and clinicians may contact the Neurology Clinical Research Unit at neurostudies@mfa.gwu.edu.

 

MMMG: Molecular Markers of Myasthenia Gravis 

Principal Investigator: Henry Kaminski, M.D.

Status of Research Trial: Active, currently recruiting

Sponsor of Research Trial: The George Washington University

Research Trial Contact Information:  For more information, interested participants and clinicians may contact the Neurology Clinical Research Unit at neurostudies@mfa.gwu.edu.